Aimovig Patient Email: A new treatment option is here
Brand: Aimovig (erenumab-aooe), Injection
Parent Company: Amgen
Drug Type: Prescription
Drug Category: Neurology
Campaign: now-approved
Targeting: Patients, Caregivers
Patient Website: https://www.aimovig.com/
HCP Website: https://www.aimovighcp.com/